Pricing Log in Create free account
Saturday 17 October 2026 Export BMY’s income statement to Excel — free account

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 5.74%, EPS grew 153.1%, free cash flow fell 13.2% and total debt fell 12.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

59.71 0.86 −1.42%
Market cap
$123.7B
P/E
13.2×
Fwd P/E
11.2×
Dividend yield
4.22%
F-score
8/9
Altman Z
2.14
Beneish M
−2.69
Dividend safety
63/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Bristol Myers Squibb Company (BMY) Operating margin

Alert me on Operating margin

Bristol Myers Squibb Company's operating margin over the twelve months to 30 June 2026 was 24.2%, up 4.9 percentage points from fiscal 2025 (19.4%). Over the past ten years it has ranged from −17.4% (fiscal 2024) to 30.5% (fiscal 2016); the current reading is higher than 73% of that period. That is above the Drug Manufacturers General industry median of 18.8% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Embed this chart

Annual newest first

Period Operating margin Change (points)
FY2025 19.4% 36.71
FY2024 −17.4% (36.10)
FY2023 18.8% 2.04
FY2022 16.7% (0.75)
FY2021 17.5% 33.62
FY2020 −16.2% (35.19)
FY2019 19.0% (7.42)
FY2018 26.5% 1.75
FY2017 24.7% (5.75)
FY2016 30.5% 17.91

Quarterly newest first

Period Operating margin Change (points)
Jun 2026 31.5% 3.31
Mar 2026 28.2% 16.42
Dec 2025 11.8% (13.71)
Sep 2025 25.5% 11.04
42 more quarters

Against its own ten years

Low −17.4% High 30.5%
Ten-year median 18.8%
Current reading's percentile 79

Operating margin against peers

Company Operating margin
NVO Novo Nordisk A/S compare 43.4%
NVS Novartis AG compare 30.2%
AMGN Amgen Inc. compare 30.0%
BMY Bristol Myers Squibb Company 24.2%
AZN AstraZeneca PLC compare 22.8%
PFE Pfizer Inc. compare 21.7%
GSK GSK PLC Sponsored ADR compare 19.6%
SNY Sanofi compare 18.2%
GILD Gilead Sciences, Inc. compare −8.20%
Drug Manufacturers General industry median 18.8%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on BMY